ALRCaN is a unique space for pediatric and adult AL oncologists worldwide to discuss best practices on an ongoing basis. This weekly collegial gathering allows KOLs and HCPs to share best practices and disseminate knowledge.
Collaborate with colleagues across ped/AYA/adult
“You know at ASH, we each (pediatric AL vs. adult AL) go to our own separate sessions and we don't go to the other discipline's sessions. This meeting is really bringing together pediatric and adult oncologists to discuss AL. There is a lot of overlap in knowledge and we should all share it.”
Dr. Dan Douer Memorial Sloan Kettering Cancer Center
Why join the Acute Leukemia Research and Care Network?
Weekly continuous education on the latest in acute leukemias
Warm and humanitarian group for networking and research collaboration
Connect with experts for case advice or limited-resource strategies
Sustituciones de asparaginasa por razones no clínicas
Dr. Scott Howard
April 10 9AM ET
Optimizing Blinatumomab
Dr. Stacy Cooper
April 15 8PM ART
Leucemia cutis: Un desafío diagnóstico y terapéutico
Dra. M. Agustina Segura Dra. Carla Pennella Dra. Laura Galluzo Dra. Elisa Sajaroff
April 17 9AM ET
Leukemia in the US Hispanic Population: Room for Improvement
Dr. Anna M. Eiring
April 22 8PM ART
Reacciones a la infusión de asparaginasa: diagnóstico, manejo agudo y uso posterior de asparaginasa
Dr. Oscar Gonzalez Ramella
April 24 9AM ET
Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL
Dr. Hisato Segoe
April 29 8PM ART
Lupus like como manifestación de EICH crónico en paciente post alotrasplante. Panorama diagnóstico y discusión de tratamiento
Dra. Lourdes Gutierrez
May 1 9AM ET
Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia
Dr. John R Wingard
May 6 8PM ART
LLA con traslocación 17;19: revisión de un caso clínico.
Dr. Jorge Ramirez
May 8 9AM ET
Scalp cooling for prevention of hair loss in pediatric ALL
Dr. Aditya Kumar Gupta
May 13 8PM ART
Sustitución de la asparaginasa por motivos clínicos: hipersensibilidad y toxicidad grave
Dr. Alberto Olaya Vargas
May 15 9AM ET
Incorporating Immunotherapy into Upfront Acute Lymphoblastic Leukemia Therapy
Dr. Mark Litzow
May 20 8PM ART
Sesión educativa y discusión de casos
Dr. Octavio Martinez
May 22 9AM ET
Infantile Leukemia: Translating Protocol into Practice Through Clinical Experience
Dr. Fatimah Hashim Mohammed
May 27 8PM ART
CAR T cells
Dra. M. Inés Pereira
May 29 9AM ET
C2S study: Surviving cancer in India: giant leaps for humankind
Dr. Ramandeep Arora
June 3 8PM ART
Sesión educativa y discusión de casos
Oncólogos pediatras miembros de GATLA
June 10 8PM ART
Sesión educativa y discusión de casos
Oncólogos pediatras miembros de SAHOP
June 12 9AM ET
Long-term follow-up of the CALGB 10403 trial: New insights into AYA ALL
Dr. Wendy Stock
June 19 9AM ET
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study
Dr. Tanja A Gruber
June 24 8PM ART
Sesión educativa y discusión de casos
Dr. Carlos Pardo
June 26 9AM ET
Global AYA ALL Status
Dr. Archie Bleyer
Newly launching ALRCaN Asia Pacific
Building bridges in APAC
Connecting clinicians, researchers, and young professionals
Sharing best practices and increasing regional insights across all of Asia Pacific
Supporting growth of the next generation of hematologists/oncologists